Increased adoption of clinical whole-genome sequencing is advancing diagnostics for rare diseases, which affect 15 million American children SAN DIEGO, Feb. 27, 2026 /PRNewswire/ -- Illumina, Inc.
Illumina's NovaSeq 6000 stands as the latest breakthrough in ultra-high throughput NGS sequencing instrumentation. This dual flow cell instrument is meticulously designed to function with four ...
During the meeting, Steve Barnard, PhD, Illumina’s CTO will provide new details about the company’s constellation mapped read technology. He will be joined by Niall Lennon, PhD, chair and CSO of Broad ...
Taiwan-based gene sequencing company Genomics BioSci & Tech has entered a strategic partnership with global sequencing leader Illumina to jointly promote gene sequencing and multi-omics technologies ...
SAN DIEGO, Feb. 27, 2026 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) today announced that Illumina Laboratory Services, Illumina's CLIA-certified laboratory, is providing clinical sequencing and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results